CN110893226A - Traditional Chinese medicine prescription for stopping hyperplasia of mammary glands - Google Patents

Traditional Chinese medicine prescription for stopping hyperplasia of mammary glands Download PDF

Info

Publication number
CN110893226A
CN110893226A CN201811066033.0A CN201811066033A CN110893226A CN 110893226 A CN110893226 A CN 110893226A CN 201811066033 A CN201811066033 A CN 201811066033A CN 110893226 A CN110893226 A CN 110893226A
Authority
CN
China
Prior art keywords
parts
hyperplasia
traditional chinese
chinese medicine
mammary glands
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201811066033.0A
Other languages
Chinese (zh)
Inventor
张文楹
张帆
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201811066033.0A priority Critical patent/CN110893226A/en
Publication of CN110893226A publication Critical patent/CN110893226A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/58—Reptiles
    • A61K35/586—Turtles; Tortoises, e.g. terrapins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232—Angelica
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/324—Boswellia, e.g. frankincense
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/42—Cucurbitaceae (Cucumber family)
    • A61K36/428—Trichosanthes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/483—Gleditsia (locust)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484—Glycyrrhiza (licorice)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A61K36/714—Aconitum (monkshood)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/902—Sparganiaceae (Bur-reed family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea

Abstract

The invention discloses a traditional Chinese medicine prescription for stopping hyperplasia of mammary glands, which comprises the following raw materials: 10-50 parts of rhizoma corydalis, 10-50 parts of angelica dahurica, 10-50 parts of rhizoma sparganii, 10-50 parts of curcuma zedoary, 10-50 parts of radix linderae, 30-100 parts of turtle shell, 15-60 parts of frankincense, 15-60 parts of myrrh, 10-50 parts of snakegourd fruit, 10-50 parts of pericarpium citri reticulatae viride, 10-50 parts of lychee seed, 10-50 parts of spina gleditsiae and 10-50 parts of liquorice, have the effect of comprehensively conditioning, carry out individualized treatment aiming at the etiology, pathogenesis and pathology of the disease, and suppress or reverse the hyperplasia of mammary glands in the development process.

Description

Traditional Chinese medicine prescription for stopping hyperplasia of mammary glands
Technical Field
The invention relates to the technical field of traditional Chinese medicines, in particular to a traditional Chinese medicine prescription for suppressing hyperplasia of mammary glands.
Background
Hyperplasia of mammary glands occurs in more than 70% of women of childbearing age, with breast distending pain and nodule enlargement occurring more often during menstrual periods and poor mood. The canceration (rate) is counted 3-5%, and gradually increased and the patient is aged less. The conventional western medicine therapy mainly comprises surgical treatment, western medicine pain relieving and hormone therapy, which can relieve the symptoms of breast diseases (hyperplasia) to a certain extent, but can not solve the problems from the etiology and pathogenesis, can not stop the dynamic change and development of breast hyperplasia, so that relapse and deterioration are caused, even the conditions of gradually aggravating and even upgrading canceration are common, once cancer is malignant, surgery, chemotherapy and targeted therapy are adopted, and serious consequences such as physical pain, economic loss and the like are caused to patients. The traditional Chinese medicine prescription for suppressing the hyperplasia of mammary glands is prepared by implementing dialectical treatment and addition and subtraction according to symptoms on the basis of a basic prescription (medicine), performing individual treatment aiming at the etiology, pathogenesis and pathology of the hyperplasia of mammary glands, suppressing or reversing the hyperplasia of mammary glands in the development process, is a preventive measure for preventing the disease, and has the advantages of rapid curative effect, lasting effect, pain improvement, rapid and obvious softening and reducing of tumor mass, and no toxic or side effect in the traditional Chinese medicine performance and the treatment process through clinical observation and accumulation.
Disclosure of Invention
The invention aims to provide a traditional Chinese medicine prescription for stopping hyperplasia of mammary glands, which solves the problems in the background technology.
In order to achieve the purpose, the invention provides the following technical scheme:
the invention relates to a traditional Chinese medicine prescription for suppressing mammary gland hyperplasia, which is refined in the clinical accumulation of the traditional Chinese medicine, and is characterized in that dialectical treatment and accompanying increase and decrease are carried out on the basis of a basic prescription to carry out individual treatment aiming at the etiology, pathogenesis and pathology of the traditional Chinese medicine, so that the mammary gland hyperplasia in the development process is suppressed or reversed.
The traditional Chinese medicine formula comprises the following raw materials: 10-50 parts of rhizoma corydalis, 10-50 parts of angelica dahurica, 10-50 parts of rhizoma sparganii, 10-50 parts of rhizoma zedoariae, 10-50 parts of radix aconiti agrestis, 30-100 parts of turtle shell, 15-60 parts of frankincense, 15-60 parts of myrrh, 10-50 parts of snakegourd fruit, 10-50 parts of pericarpium citri reticulatae viride, 10-50 parts of lychee seed, 10-50 parts of spina gleditsiae and 10-50 parts of liquorice.
The optimal raw material ratio of the traditional Chinese medicine formula is as follows: 30 parts of angelica dahurica, 30 parts of rhizoma sparganii, 30 parts of curcuma zedoary, 30 parts of radix aconiti agrestis, 65 parts of turtle shell, 40 parts of frankincense, 40 parts of myrrh, 30 parts of snakegourd fruit, 30 parts of green tangerine peel, 30 parts of lychee seed, 30 parts of spina gleditsiae and 30 parts of liquorice.
The preparation method comprises the following steps: all the medicines are subjected to superfine crushing, sieving and processing into water-bindered pills.
The using method comprises the following steps: the medicine is taken twice a day, 10 g each time, and is taken in the morning and the evening.
In the formula, radix angelicae is used for expelling wind-damp, promoting blood circulation and expelling pus, promoting vital function and relieving pain, rhizoma sparganii is used for stopping bleeding, promoting digestion and harmonizing stomach, breaking blood and promoting qi circulation, rhizoma zedoariae is used for breaking qi and promoting blood circulation, removing food retention and relieving pain, and resisting tumors, radix aconiti taicae is used for promoting qi circulation and relieving pain, warming kidney and dispelling cold, carapax amydae is used for nourishing yin and suppressing yang, softening hardness and dissipating binds, removing heat and removing steaming, frankincense is used for diminishing inflammation and preventing corrosion, stimulating menstrual flow and relieving pain, and promoting granulation, myrrh is used for promoting blood circulation and relieving pain, removing swelling and promoting vital function, dissipating blood stasis and removing heat and reducing phlegm, benefiting qi and relieving chest stuffiness, dispersing green tangerine peel is used for soothing liver and relieving qi, removing food retention and eliminating stagnation.
Compared with the prior art, the invention has the beneficial effects that: nourishing qi and blood to ensure sufficient qi and blood, reinforcing primordial qi, consolidating constitution, nourishing kidney qi, dissipating blood stasis, dispersing stagnated liver qi, regulating qi-flowing, promoting blood circulation for removing blood stasis, dredging mammary gland collaterals, softening and resolving hard mass, eliminating inflammation, eliminating stasis toxin in mammary gland, regulating visceral function, regulating functions of breast, and treating individual diseases and pathological conditions to arrest or reverse hyperplasia of mammary glands.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
In the embodiment of the invention, a traditional Chinese medicine prescription for suppressing hyperplasia of mammary glands is prepared from the following raw medicinal materials in percentage by mass: 30 parts of angelica dahurica, 30 parts of rhizoma sparganii, 30 parts of curcuma zedoary, 30 parts of radix aconiti agrestis, 65 parts of turtle shell, 40 parts of frankincense, 40 parts of myrrh, 30 parts of snakegourd fruit, 30 parts of green tangerine peel, 30 parts of lychee seed, 30 parts of spina gleditsiae and 30 parts of liquorice, all the medicines are subjected to superfine crushing, sieving and processing into water pills, the water pills are processed into water pills, the whole medicine components are stored, the loss of the effective medicine components caused by other processed dosage forms is avoided, and the traditional Chinese medicine is taken twice a day, 10 g each time and is taken in the morning and evening.
It will be evident to those skilled in the art that the invention is not limited to the details of the foregoing illustrative embodiments, and that the present invention may be embodied in other specific forms without departing from the spirit or essential attributes thereof. The present embodiments are therefore to be considered in all respects as illustrative and not restrictive, the scope of the invention being indicated by the appended claims rather than by the foregoing description, and all changes which come within the meaning and range of equivalency of the claims are therefore intended to be embraced therein.
Furthermore, it should be understood that although the present description refers to embodiments, not every embodiment may contain only a single embodiment, and such description is for clarity only, and those skilled in the art should integrate the description, and the embodiments may be combined as appropriate to form other embodiments understood by those skilled in the art.

Claims (3)

1. The traditional Chinese medicine prescription for suppressing hyperplasia of mammary glands is characterized by comprising the following raw materials: 10-50 parts of rhizoma corydalis, 10-50 parts of angelica dahurica, 10-50 parts of rhizoma sparganii, 10-50 parts of curcuma zedoary, 10-50 parts of radix aconiti agrestis, 30-100 parts of turtle shell, 15-60 parts of frankincense, 15-60 parts of myrrh, 10-50 parts of snakegourd fruit, 10-50 parts of pericarpium citri reticulatae viride, 10-50 parts of lychee seed, 10-50 parts of spina gleditsiae and 10-50 parts of liquorice, and the raw materials are ground into superfine powder.
2. The traditional Chinese medicine prescription for suppressing hyperplasia of mammary glands according to claim 1, wherein the pulverized raw materials are sieved and processed into watered pills, which are taken twice a day, 10 g each time in the morning and evening.
3. The traditional Chinese medicine prescription for suppressing hyperplasia of mammary glands according to claim 1, wherein the optimal raw material ratio of each prescription is as follows: 30 parts of angelica dahurica, 30 parts of rhizoma sparganii, 30 parts of curcuma zedoary, 30 parts of radix aconiti agrestis, 65 parts of turtle shell, 40 parts of frankincense, 40 parts of myrrh, 30 parts of snakegourd fruit, 30 parts of green tangerine peel, 30 parts of lychee seed, 30 parts of spina gleditsiae and 30 parts of liquorice.
CN201811066033.0A 2018-09-13 2018-09-13 Traditional Chinese medicine prescription for stopping hyperplasia of mammary glands Pending CN110893226A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811066033.0A CN110893226A (en) 2018-09-13 2018-09-13 Traditional Chinese medicine prescription for stopping hyperplasia of mammary glands

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811066033.0A CN110893226A (en) 2018-09-13 2018-09-13 Traditional Chinese medicine prescription for stopping hyperplasia of mammary glands

Publications (1)

Publication Number Publication Date
CN110893226A true CN110893226A (en) 2020-03-20

Family

ID=69785180

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811066033.0A Pending CN110893226A (en) 2018-09-13 2018-09-13 Traditional Chinese medicine prescription for stopping hyperplasia of mammary glands

Country Status (1)

Country Link
CN (1) CN110893226A (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102727832A (en) * 2012-07-09 2012-10-17 王焕江 Chinese medicinal preparation for treating breast diseases and uterine fibroid and preparation method thereof
CN104997912A (en) * 2015-07-09 2015-10-28 四川金堂海纳生物医药技术研究所 Oral medicine for effectively treating mammary gland hyperplasia, and preparation method thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102727832A (en) * 2012-07-09 2012-10-17 王焕江 Chinese medicinal preparation for treating breast diseases and uterine fibroid and preparation method thereof
CN104997912A (en) * 2015-07-09 2015-10-28 四川金堂海纳生物医药技术研究所 Oral medicine for effectively treating mammary gland hyperplasia, and preparation method thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
孙杨: "乳腺增生病中药用药规律分析", 《山东中医杂志》 *
弭阳: "神效瓜蒌散治疗乳腺增生病128例", 《湖南中医杂志》 *

Similar Documents

Publication Publication Date Title
CN104523865B (en) Medicine for treating breast diseases
CN111097030A (en) Traditional Chinese medicine composition for treating tumors and relieving tumor pain and preparation method thereof
CN101085184A (en) Traditional Chinese medicine for treating breast cancer
CN110893226A (en) Traditional Chinese medicine prescription for stopping hyperplasia of mammary glands
CN115814046A (en) Traditional Chinese medicine composition for treating mastitis and application thereof
CN103083387A (en) Congestion-eliminating pain-relieving plaster
CN103784932A (en) Traditional Chinese medicine decoction for treating hyperplasia of mammary glands
CN103656530B (en) A kind of Chinese medicine composition for the treatment of cyclomastopathy
CN104997972A (en) Traditional Chinese medicine preparation for treating radiodermatitis
CN103191369B (en) Chinese medicinal composition for treating mammary gland hyperplasia
CN102078432A (en) Medicament for treating skin itch
CN105535902A (en) Externally dressed ointment for treating intervertebral disc herniation
CN104491511A (en) Traditional Chinese medicine external-applying preparation for treating hyperplasia of mammary glands
CN103536745B (en) A kind of Chinese kmedicine bolus for the treatment of cyclomastopathy
CN103893328B (en) Traditional Chinese medicine pill used for treating hyperplasia of mammary glands
CN101810668A (en) Toxin drawing plaster
CN101791372A (en) Chinese medicine for treating radiation pharyngitis
CN105343423B (en) A kind of drug and preparation method thereof for treating eczema
CN103751293A (en) Traditional Chinese medicinal composition for treating chronic nephritis
CN103223046A (en) Traditional Chinese medicine for treating hyperplasia of mammary glands
CN106606735A (en) Medicine for treating proliferation of mammary glands
CN1226443A (en) External used ointment for mammary cancer and preparing method thereof
CN107260954A (en) A kind of traditional Chinese herbal decoction for treating hyperplasia of mammary glands
CN106139041A (en) A kind of formula Chinese medicine treating the proliferation of mammary gland
CN105250641A (en) Traditional Chinese medicine composition for treating rheumatism

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20200320